139 related articles for article (PubMed ID: 18504149)
1. The effects of bisphosphonates on osteoblasts in vitro.
Naidu A; Dechow PC; Spears R; Wright JM; Kessler HP; Opperman LA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):5-13. PubMed ID: 18504149
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
3. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6.
Tipton DA; Seshul BA; Dabbous MKh
J Periodontal Res; 2011 Feb; 46(1):39-47. PubMed ID: 20701670
[TBL] [Abstract][Full Text] [Related]
4. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
7. Increased Tgf-beta1 production by rat osteoblasts in the presence of PepGen P-15 in vitro.
Trasatti C; Spears R; Gutmann JL; Opperman LA
J Endod; 2004 Apr; 30(4):213-7. PubMed ID: 15085048
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.
Kobayashi A; Hirano F; Makino I
Scand J Rheumatol; 2005; 34(6):480-4. PubMed ID: 16393773
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative.
Lee AZ; Jiang J; He J; Safavi KE; Spangberg LS; Zhu Q
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):133-8. PubMed ID: 18585627
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast proliferation and maturation by bisphosphonates.
Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
[TBL] [Abstract][Full Text] [Related]
12. Cyclic mechanical strain increases production of regulators of bone healing in cultured murine osteoblasts.
Singh SP; Chang EI; Gossain AK; Mehara BJ; Galiano RD; Jensen J; Longaker MT; Gurtner GC; Saadeh PB
J Am Coll Surg; 2007 Mar; 204(3):426-34. PubMed ID: 17324777
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
15. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
16. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
17. The upregulation of receptor activator NF-kappaB ligand expression by interleukin-1alpha and Porphyromonas endodontalis in human osteoblastic cells.
Chen SC; Huang FM; Lee SS; Li MZ; Chang YC
Int Endod J; 2009 Apr; 42(4):375-80. PubMed ID: 19298221
[TBL] [Abstract][Full Text] [Related]
18. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
[TBL] [Abstract][Full Text] [Related]
19. Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells.
Bayram H; Kenar H; Taşar F; Hasırcı V
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):140-6. PubMed ID: 22571861
[TBL] [Abstract][Full Text] [Related]
20. [Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast].
Zhang XM; Xie H; Yuan LQ; Luo XH; Liao EY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1562-5. PubMed ID: 18956641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
